Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Abstract Text:

Vesicular stomatitis virus (VSV) is a candidate oncolytic virus that replicates and induces cell death in cancer cells while sparing normal cells. Although defects in the interferon antiviral response facilitate VSV oncolysis, other host factors, including translational and growth regulatory mechanisms, also appear to influence oncolytic virus activity. We previously demonstrated that VSV infection induces apoptosis in proliferating CD4(+) T lymphocytes from adult T-cell leukemia samples but not in resting T lymphocytes or primary chronic lymphocytic leukemia cells that remain arrested in G(0). Activation of primary CD4(+) T lymphocytes with anti-CD3/CD28 is sufficient to induce VSV replication and cell death in a manner dependent on activation of the MEK1/2, c-Jun NH(2)-terminal kinase, or phosphatidylinositol 3-kinase pathway but not p38. VSV replication is specifically impaired by the cell cycle inhibitor olomoucine or rapamycin, which induces early G(1) arrest, but not by aphidicolin or Taxol, which blocks at the G(1)1S or G(2)1M phase, respectively; this result suggests a requirement for cell cycle entry for efficient VSV replication. The relationship between increased protein translation following G(0)/G(1) transition and VSV permissiveness is highlighted by the absence of mTOR and/or eIF4E phosphorylation whenever VSV replication is impaired. Furthermore, VSV protein production in activated T cells is diminished by small interfering RNA-mediated eIF4E knockdown. These results demonstrate that VSV replication in primary T lymphocytes relies on cell cycle transition from the G(0) phase to the G(1) phase, which is characterized by a sharp increase in ribogenesis and protein synthesis.

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of virology

VOLUME: 82

Page Numbers: 5735-49

Journal Abbreviation: J. Virol.

ISSN: 1098-5514

DAY: 16

MONTH: 04

YEAR: 2008

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 113724

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.

AFFILIATION: Lady Davis Institute for Medical Research, 3755 Cote Ste. Catherine, Montreal, Quebec, Canada H3T 1E2. john.hiscott@mcgill.ca.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Virol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation Related Publications

• Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.
• Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response.
• Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells.
• Health services in four isolated districts in Nova Scotia.
• Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).
• Human papillomavirus in pterygium.
• Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
• Neoplastic transformation of ciliary body epithelium is associated with loss of opticin expression.
• RIG-I has guts: identification of a role for RIG-I in colitis development.
• SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation.
• Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
• Temporal pterygium: benign or not?
• Ub Surprised: Viral Ovarian Tumor Domain Proteases Remove Ubiquitin and ISG15 Conjugates.
• Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.